Effect of continuous positive airway pressure on symptoms of anxiety and depression in patients with obstructive sleep apnea
© 2020. The Author(s)..
PURPOSE: The objective was to assess the effect of continuous positive airway pressure (CPAP) on symptoms of anxiety and depression in patients with obstructive sleep apnea (OSA). We hypothesized a decrease in symptoms at follow-up, but that improvement relied on CPAP adherence.
METHODS: The sample comprised 468 patients (mean age 55.5 years (SD = 12.0), 72% men) with OSA who received CPAP at a Norwegian hospital. OSA was diagnosed according to standard respiratory polygraphy. Mean baseline respiratory event index (REI) was 28.4 (SD = 20.6). Symptoms of anxiety and depression were assessed prior to CPAP treatment and at follow-up after a median of 20 weeks, range 6-52 weeks, with the Hospital Anxiety and Depression Scale (HADS). Patients were classified as CPAP adherent (≥ 4 h per night) or non-adherent (< 4 h per night).
RESULTS: There was a significant decrease in anxiety scores from baseline (mean = 5.16, SD = 3.94) to follow-up (mean = 4.76, SD = 3.81), p < 0.001. Similarly, depression scores decreased from baseline (mean = 4.31, SD = 3.66) to follow-up (mean = 3.89, SD = 3.69), p < 0.001. Cohen's d (0.19 and 0.18, respectively) indicated small effect sizes. The reduction in anxiety scores did not depend on CPAP adherence (no interaction effect F(1, 466) = 0.422, p = 0.516), whereas the reduction in depression scores were seen only in the CPAP adherent group (interaction effect F(1, 466) = 7.738, p = 0.006).
CONCLUSIONS: We found a decrease in symptoms of anxiety and depression from baseline to follow-up of CPAP treatment. The improvement in symptoms of depression was depending on CPAP adherence. This underlines the importance of adherence for optimal effect of CPAP treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Sleep & breathing = Schlaf & Atmung - 25(2021), 3 vom: 24. Sept., Seite 1277-1283 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lundetræ, Ragnhild Stokke [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 17.12.2021 Date Revised 18.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11325-020-02234-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316673765 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316673765 | ||
003 | DE-627 | ||
005 | 20231225161610.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11325-020-02234-7 |2 doi | |
028 | 5 | 2 | |a pubmed24n1055.xml |
035 | |a (DE-627)NLM316673765 | ||
035 | |a (NLM)33098538 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lundetræ, Ragnhild Stokke |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of continuous positive airway pressure on symptoms of anxiety and depression in patients with obstructive sleep apnea |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.12.2021 | ||
500 | |a Date Revised 18.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020. The Author(s). | ||
520 | |a PURPOSE: The objective was to assess the effect of continuous positive airway pressure (CPAP) on symptoms of anxiety and depression in patients with obstructive sleep apnea (OSA). We hypothesized a decrease in symptoms at follow-up, but that improvement relied on CPAP adherence | ||
520 | |a METHODS: The sample comprised 468 patients (mean age 55.5 years (SD = 12.0), 72% men) with OSA who received CPAP at a Norwegian hospital. OSA was diagnosed according to standard respiratory polygraphy. Mean baseline respiratory event index (REI) was 28.4 (SD = 20.6). Symptoms of anxiety and depression were assessed prior to CPAP treatment and at follow-up after a median of 20 weeks, range 6-52 weeks, with the Hospital Anxiety and Depression Scale (HADS). Patients were classified as CPAP adherent (≥ 4 h per night) or non-adherent (< 4 h per night) | ||
520 | |a RESULTS: There was a significant decrease in anxiety scores from baseline (mean = 5.16, SD = 3.94) to follow-up (mean = 4.76, SD = 3.81), p < 0.001. Similarly, depression scores decreased from baseline (mean = 4.31, SD = 3.66) to follow-up (mean = 3.89, SD = 3.69), p < 0.001. Cohen's d (0.19 and 0.18, respectively) indicated small effect sizes. The reduction in anxiety scores did not depend on CPAP adherence (no interaction effect F(1, 466) = 0.422, p = 0.516), whereas the reduction in depression scores were seen only in the CPAP adherent group (interaction effect F(1, 466) = 7.738, p = 0.006) | ||
520 | |a CONCLUSIONS: We found a decrease in symptoms of anxiety and depression from baseline to follow-up of CPAP treatment. The improvement in symptoms of depression was depending on CPAP adherence. This underlines the importance of adherence for optimal effect of CPAP treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Anxiety | |
650 | 4 | |a CPAP | |
650 | 4 | |a Depression | |
650 | 4 | |a HADS | |
650 | 4 | |a OSA | |
650 | 4 | |a Sleep apnea | |
700 | 1 | |a Saxvig, Ingvild West |e verfasserin |4 aut | |
700 | 1 | |a Lehmann, Sverre |e verfasserin |4 aut | |
700 | 1 | |a Bjorvatn, Bjørn |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Sleep & breathing = Schlaf & Atmung |d 1997 |g 25(2021), 3 vom: 24. Sept., Seite 1277-1283 |w (DE-627)NLM097422169 |x 1522-1709 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2021 |g number:3 |g day:24 |g month:09 |g pages:1277-1283 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11325-020-02234-7 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2021 |e 3 |b 24 |c 09 |h 1277-1283 |